Isatuximab is a medication used to treat multiple myeloma, a type of blood cancer. It works by targeting a specific protein on cancer cells, helping the immune system to identify and destroy these cells.

Belantamab mafodotin is also a medication used to treat multiple myeloma. It works by delivering a cancer-killing substance directly to cancer cells that express a specific protein called BCMA.

Dexamethasone is a corticosteroid medication that helps reduce inflammation and suppress the immune system. In multiple myeloma treatment, it is often used in combination with other medications to enhance their effectiveness and manage certain side effects.

Multiple Myeloma – A type of blood cancer that develops in plasma cells, which are white blood cells that normally produce antibodies to help fight infections. In this disease, cancerous plasma cells accumulate in the bone marrow, crowding out healthy blood cells and producing abnormal proteins. These abnormal cells can cause bone damage, kidney problems, and a decrease in normal blood cell production. Multiple myeloma often develops slowly and may progress through different stages, from early disease to relapsed or refractory forms. The condition typically affects multiple areas of the body where bone marrow is active.

Cancer – A disease characterized by the uncontrolled growth and spread of abnormal cells in the body. These cells divide and grow uncontrollably, forming masses or tumors that can invade nearby tissues. Cancer cells can break away from their original location and spread to other parts of the body through blood vessels or lymph nodes. The disease can develop in almost any organ or tissue and may affect normal body functions as it progresses. Cancer typically develops gradually, often starting from a single abnormal cell that multiplies over time.